Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.85
+0.05 (0.17%)
At close: Dec 10, 2025, 4:00 PM EST
25.87
+0.02 (0.08%)
After-hours: Dec 10, 2025, 4:10 PM EST
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.93 billion as of December 10, 2025. Its market cap has increased by 105.32% in one year.
Market Cap
1.93B
Enterprise Value
1.65B
1-Year Change
105.32%
Ranking
Category
Stock Price
$25.85
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.93B, an increase of 487.29%. That is a compound annual growth rate of 22.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 1.93B | 91.51% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |